The DOI matches its Crossref record.
Hypoglycemia in the Diabetes Control and Complications Trial
Abstract
A total of 1,441 patients with IDDM were randomly assigned to receive either intensive (n = 711) or conventional (n = 730) diabetes therapy in the Diabetes Control and Complications Trial (DCCT). The patients were followed for an average of 6.5 years. Subjects were instructed to report all episodes of suspected severe hypoglycemia to their health care team. In addition, at quarterly follow-up visits, each subject was asked about the occurrence of severe hypoglycemia. There were 3,788 episodes of severe hypoglycemia (requiring assistance); 1,027 of these episodes were associated with coma and/or seizure. A total of 65% percent of patients in the intensive group vs. 35% of patients in the conventional group had at least one episode of severe hypoglycemia by the study end; the overall rates of severe hypoglycemia were 61.2 per 100 patient-years vs. 18.7 per 100 patient-years in the intensive and conventional treatment groups, respectively, with a relative risk (RR) of 3.28. The relative risk for coma and/or seizure was 3.02 for intensive therapy. The increased risk with intensive treatment persisted over each of the 9 years of follow-up in the DCCT and over the calendar years 1984–1993 during which the study was conducted. When baseline patient characteristics were examined for effects on the risk of severe hypoglycemia, the relative risk of hypoglycemia for intensive versus conventional treatment was ≥2 for all subgroups. Several subgroups defined by baseline characteristics, including males, adolescents, and subjects with no residual C-peptide or with a prior history of hypoglycemia, had a particularly high risk of severe hypoglycemia in both treatment groups. Analyses of the cumulative incidence of successive episodes indicated that intensive treatment was also associated with an increased risk of multiple episodes within the same patient (e.g., 22% experienced five or more episodes of severe hypoglycemia within the first 5 years of follow-up vs. 4% in the conventional group). Within both treatment groups, patients who experienced severe hypoglycemia were at increased risk of subsequent episodes. Approximately 30% of patients in each group experienced a second episode within the 4 months following the first episode of severe hypoglycemia. Within each treatment group, the number of prior episodes of hypoglycemia was the strongest predictor of the risk of future episodes, followed closely by the current HbA1c value. After adjustment for the current quarterly HbA1c level, intensive treatment was still associated with a significantly increased risk of hypoglycemia, indicating that the increased risk with intensive treatment is not completely explained by differences in HbA1c values.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Randomized controlled trials have established that intensive glycemic therapy prevents or delays the microvascular complications-retinopathy, nephropathy, and neuropathy-of diabetes (122, 123, 131, 144, 145), albeit at the expense of an increased frequency of hypoglycemia (117, 118, 122, 123, 132, 133, 144, 145).”
From Evaluation and Management of Adult Hypoglycemic Disorders: An Endocrine Society Clinical Practice Guideline (2009) · cites this paper as [133]
In the citing paper
“A glucose of <70 mg/dL (3.9 mmol/L) is the classic threshold for hypoglycemia based on physiologic glucose regulation and neuroendocrine response in persons without DM.1197”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1197]
Citations
Cites
Still being checked.
Cited by
Items 201–300 of 779
Blood Glucose Awareness Training: What Is It, Where Is It, and Where Is It Going?
Cox, D. J., Gonder-Frederick, L., Ritterband, L., Patel, K., Schächinger, H., Fehm-Wolfsdorf, G., Hermanns, N., Snoek, F., Zrebiec, J., Polonsky, W., et al. (2006) · Diabetes Spectrum · doi:10.2337/diaspect.19.1.43 · Cited by 68
Guettier, J.-M., & Gorden, P. (2006) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2006.09.005 · Cited by 68
Ang, E., Lee, Z. X., Moore, S. L., & Nana, M. (2020) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2020.107559 · Cited by 76
Hermanns, N., Heinemann, L., Freckmann, G., Waldenmaier, D., & Ehrmann, D. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819831695 · Cited by 66
García‐Casares, N., Berthier, M. L., Jorge, R. E., Gonzalez-Alegre, P., Cardo, A. G., Rioja, J., Ación, L., Corbo, M. J. A., Nabrozidis, A., García-Arnés, J. A., et al. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-131736 · Cited by 75
Lu, C., Shen, H.-N., Hu, S. C., Wang, J., & Li, C. (2016) · Diabetes Care · doi:10.2337/dc15-2418 · Cited by 66
Nuclear Cardiology: Present and Future
Russell, R. R., & Zaret, B. L. (2006) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2006.05.002 · Cited by 68
A Low Carbohydrate Diet in Type 1 Diabetes
Nielsen, J. V., Jönsson, E., & Ivarsson, A. (2005) · Upsala Journal of Medical Sciences · doi:10.3109/2000-1967-074 · Cited by 65
Li, C., Li, J., Zhang, Q.-M., Lv, L., Chen, R., Lv, C.-F., Yu, P., & Yu, D. M. (2012) · Cardiovascular Diabetology · doi:10.1186/1475-2840-11-142 · Cited by 65
Danne, T., Cariou, B., Buse, J. B., Garg, S. K., Rosenstock, J., Banks, P. L., Kushner, J. A., McGuire, D. K., Peters, A. L., Sawhney, S., et al. (2019) · Diabetes Care · doi:10.2337/dc18-2149 · Cited by 66
Craig, M. E., Jones, T. W., Silink, M., & Ping, Y. J. (2007) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2006.04.005 · Cited by 75
Mandrup-Poulsen, T. R. (1998) · BMJ · doi:10.1136/bmj.316.7139.1221 · Cited by 64
Presence of Macroalbuminuria Predicts Severe Hypoglycemia in Patients With Type 2 Diabetes
Yun, J., Ko, S.-H., Ko, S.-H., Song, K., Ahn, Y., Yoon, K., Park, Y., & Ko, S. (2012) · Diabetes Care · doi:10.2337/dc12-1408 · Cited by 64
Vora, J. P., & Heise, T. (2013) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12087 · Cited by 67
Vigersky, R. A. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814565661 · Cited by 72
Hypoglycemia in Type 1 Diabetic Pregnancy
Heller, S. R., Damm, P., Mersebach, H., Skjøth, T. V., Kaaja, R., Hod, M., Durán-Garcia, S., McCance, D. R., & Mathiesen, E. R. (2009) · Diabetes Care · doi:10.2337/dc09-1605 · Cited by 63
Stable Liquid Glucagon: Beyond Emergency Hypoglycemia Rescue
Wilson, L. M., & Castle, J. R. (2018) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818757795 · Cited by 65
HbA1c, systolic blood pressure variability and diabetic retinopathy in Asian type 2 diabetics
Foo, V. H. X., Quah, J. H. M., Cheung, C. M. G., Tan, N. C., Zar, K. L. M., Chan, C. M., Lamoureux, E. L., Yin, W. T., Tan, G. S. W., & Sabanayagam, C. (2016) · Journal of Diabetes · doi:10.1111/1753-0407.12403 · Cited by 65
Zhong, V. W., Juhaeri, J., Cole, S. R., Kontopantelis, E., Shay, C. M., Gordon‐Larsen, P., & Mayer‐Davis, E. J. (2017) · Diabetes Care · doi:10.2337/dc16-2680 · Cited by 62
Dose adjustment for normal eating (DAFNE)—an audit of outcomes in Australia
McIntyre, H. D., Knight, B. A., Harvey, D. M., Noud, M. N., Hagger, V. L., & Gilshenan, K. S. (2010) · Medical Journal of Australia · doi:10.5694/j.1326-5377.2010.tb03662.x · Cited by 61
Diabetes Research in Children Network (DirecNet) Study Group (2009) · Diabetes Care · doi:10.2337/dc08-2298 · Cited by 61
Factors Predictive of Severe Hypoglycemia in Type 1 Diabetes
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group (2011) · Diabetes Care · doi:10.2337/dc10-1111 · Cited by 65
Gruden, G., Giunti, S., Barutta, F., Chaturvedi, N., Witte, D. R., Tricarico, M., Fuller, J., Perin, P. C., & Bruno, G. (2011) · Diabetes Care · doi:10.2337/dc11-1739 · Cited by 60
Gagliardino, J. J., Chantelot, J.-M., Domenger, C., Ramachandran, A., KADDAHA, G., Mbanya, J. C., Shestakova, M. V., & Chan, J. C. N. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.09.008 · Cited by 75
Hepatic insulin production for type 1 diabetes
Dong, H. H., & Woo, S. L. C. (2001) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(01)00491-x · Cited by 62
Holmes-Walker, D. J., Gunton, J. E., Hawthorne, W. J., Payk, M., Anderson, P., Donath, S. M., Loudovaris, T., Ward, G. M., Kay, T. W. H., & O’Connell, P. J. (2016) · Transplantation · doi:10.1097/tp.0000000000001381 · Cited by 66
At last, a weight neutral insulin?
Fritsche, A., & Häring, H.-U. (2004) · International Journal of Obesity · doi:10.1038/sj.ijo.0802749 · Cited by 64
Biphasic insulin aspart 30 plus metformin: an effective combination in type 2 diabetes
Kvapil, M., Сватко, А., Hilberg, C., & Shestakova, M. V. (2005) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2005.00492.x · Cited by 58
de Souza, B. M., Bouças, A. P., de Oliveira, F. D. S., Reis, K. P., Ziegelmann, P. K., Bauer, A. C., & Crispim, D. (2017) · Islets · doi:10.1080/19382014.2017.1286434 · Cited by 62
Microdosing for drug delivery application—A review
Bußmann, A. B., Grünerbel, L., Durasiewicz, C. P., Thalhofer, T., Wille, A., & Richter, M. (2021) · Sensors and Actuators A Physical · doi:10.1016/j.sna.2021.112820 · Cited by 63
Henriksen, M. M., Andersen, H. U., Thorsteinsson, B., & Pedersen-Bjergaard, U. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00142 · Cited by 57
Ng, S. M., Wright, N. P., Yardley, D., Campbell, F., Randell, T. L., Trevelyan, N., Ghatak, A., & Hindmarsh, P. C. (2022) · Diabetic Medicine · doi:10.1111/dme.15015 · Cited by 61
The Changing Epidemiology of Type 1 Diabetes: A Global Perspective
Bell, K. J., & Lain, S. J. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16501 · Cited by 73
Islet cell transplantation today
Bretzel, R. G., Jahr, H., Eckhard, M., Martin, I., Winter, D., & Brendel, M. D. (2007) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-007-0183-4 · Cited by 59
Fanelli, C. G., Pampanelli, S., Porcellati, F., Rossetti, P., Brunetti, P., & Bolli, G. B. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-136-7-200204020-00007 · Cited by 58
Hypoglycemia Reduction and Changes in Hemoglobin A1c in the ASPIRE In-Home Study
Weiss, R., Garg, S. K., Bode, B. W., Bailey, T. S., Ahmann, A., Schultz, K. A., Welsh, J. B., Shin, J., & for the ASPIRE In-Home Study Group (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0306 · Cited by 55
Calles-Escandón, J., Koch, K. L., Hasler, W. L., Van Natta, M. L., Pasricha, P. J., Tonascia, J., Parkman, H. P., Hamilton, F., Herman, W. H., Basina, M., et al. (2018) · PLOS ONE · doi:10.1371/journal.pone.0194759 · Cited by 55
Mueller, E., Maxion‐Bergemann, S., Gultyaev, D., Walzer, S., Freemantle, N., Mathieu, C., Bolinder, B., Gerber, R. A., Kvasz, M., & Bergemann, R. (2006) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2006.8.219 · Cited by 63
P REHOSPITAL H YPOGLYCEMIA : T HE S AFETY OF N OT T RANSPORTING T REATED P ATIENTS
Cain, E., Ackroyd-Stolarz, S. A., Alexiadis, P., & Murray, D. D. (2003) · Prehospital Emergency Care · doi:10.1080/312703002193 · Cited by 53
Melatonin prolongs islet graft survival in diabetic NOD mice
Lin, G., Huang, S., Chen, Y., Hueng, D., Chien, M., Chia, W., Chang, D., & Sytwu, H. (2009) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2009.00712.x · Cited by 54
Drug-Induced Endocrine and Metabolic Disorders
Ronald, C. W., Kong, A. P. S., Chan, N. N., Tong, P. C. Y., & Chan, J. C. N. (2007) · Drug Safety · doi:10.2165/00002018-200730030-00005 · Cited by 57
Bulsara, M. K., Holman, C. D. J., Davis, E. A., & Jones, T. W. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01250.x · Cited by 60
Insulin expression in livers of diabetic mice mediated by hydrodynamics-based administration
He, C., Shi, D., Wu, W., Ding, Y., Feng, D., Lu, B., Chen, H.-M., Yao, J., Shen, Q., Lu, D., et al. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i4.567 · Cited by 54
Bruderer, S. G., Bodmer, M., Jick, S. S., Bader, G., Schlienger, R. G., & Meier, C. R. (2014) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12282 · Cited by 53
Juhl, C. B., Højlund, K., Madsen, R. E., Poulsen, M. K., Selmar, P. E., Holst, J. J., Christiansen, C., & Beck‐Nielsen, H. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2010.01.007 · Cited by 55
Insulin analogues and severe hypoglycaemia in type 1 diabetes
Kristensen, P. L., Hansen, L., Jespersen, M. J., Pedersen‐Bjergaard, U., Beck‐Nielsen, H., Christiansen, J. S., Nørgaard, K., Perrild, H., Parving, H.-H., Thorsteinsson, B., et al. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.10.046 · Cited by 53
Burnett, D. R., Huyett, L. M., Zisser, H. C., Doyle, F. J., & Mensh, B. D. (2014) · Diabetes · doi:10.2337/db13-1649 · Cited by 52
N of 1 trials in diabetes: making individual therapeutic decisions
Τσάπας, Α., & Matthews, D. R. (2008) · Diabetologia · doi:10.1007/s00125-008-0983-2 · Cited by 53
Severe Hypoglycemia: Is It Still a Threat for Children and Adolescents With Type 1 Diabetes?
Urakami, T. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00609 · Cited by 59
Hering, B. J., Ballou, C. M., Bellin, M. D., Payne, E. H., Kandeel, F., Witkowski, P., Alejandro, R., Rickels, M. R., & Barton, F. B. (2023) · Diabetologia · doi:10.1007/s00125-022-05804-4 · Cited by 51
Effect of pioglitazone therapy in lean type1 diabetes mellitus
Bhat, R. V., Bhansali, A. K., Bhadada, S. K., & Sialy, R. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.04.012 · Cited by 53
Exposure to hypoglycemia and risk of stroke
Smith, L., Chakraborty, D., Bhattacharya, P., Sarmah, D., Koch, S., & Dave, K. R. (2018) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13872 · Cited by 58
The Epidemiology of Diabetic Retinopathy
Klein, R. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-563-3_3 · Cited by 58
Parental Attitudes Towards Overnight Closed-Loop Glucose Control in Children with Type 1 Diabetes
Elleri, D., Acerini, C. L., Allen, J. M., Hayes, J., Pesterfield, C., Wilinska, M. E., Dunger, D. B., & Hovorka, R. (2010) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2009.0084 · Cited by 51
Racial disparities in access to simultaneous pancreas-kidney transplantation in the United States
Isaacs, R. B., Lobo, P. I., Nock, S. L., Hanson, J. A., OJO, A. O., & Pruett, T. L. (2000) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2000.9793 · Cited by 50
Recovery of endocrine function after islet and pancreas transplantation
Rickels, M. R. (2012) · Current Diabetes Reports · doi:10.1007/s11892-012-0294-3 · Cited by 49
Economic impact of hypoglycemia on healthcare in Spain
Brito-Sanfiel, M. Á., Diago, J. I., & Calderón, A. (2010) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/erp.10.73 · Cited by 49
Noradrenergic Activity in the Human Brain: A Mechanism Supporting the Defense Against Hypoglycemia
Belfort‐DeAguiar, R., Gallezot, J., Hwang, J. J., Elshafie, A., Yeckel, C. W., Chan, O. T. M., Carson, R. E., Ding, Y., & Sherwin, R. S. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02717 · Cited by 48
Haynes, A., Hermann, J. M., Clapin, H. F., Hofer, S. E., Karges, B., Jones, T. W., Davis, E. A., & Holl, R. W. (2019) · Diabetes Care · doi:10.2337/dc18-2448 · Cited by 51
Hypoglycemia preceding fatal car collisions
Cox, D. J., Kovatchev, B., Vandecar, K., Gonder-Frederick, L., Ritterband, L., & Clarke, W. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1836 · Cited by 48
Little, S. A., Leelarathna, L., Barendse, S. M., Walkinshaw, E., Tan, H. K., Lubina Solomon, A., de Zoysa, N., Rogers, H., Choudhary, P., Amiel, S. A., et al. (2014) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2492 · Cited by 48
Mathieu, C., Dandona, P., Phillip, M., Oron, T., Lind, M., Hansen, L., THOREN, F. A., Xu, J. L., Langkilde, A. M., & on behalf of the DEPICT-1 and DEPICT-2 Investigators (2019) · Diabetes Care · doi:10.2337/dc18-1983 · Cited by 50
Hepatic insulin expression improves glycemic control in type 1 diabetic rats
Dong, H. H., Morral, N., McEvoy, R. C., Meseck, M. L., Thung, S. N., & Woo, S. L. C. (2001) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(01)00220-0 · Cited by 47
Potential role of non‐insulin adjunct therapy in Type 1 diabetes
George, P., & McCrimmon, R. J. (2012) · Diabetic Medicine · doi:10.1111/j.1464-5491.2012.03744.x · Cited by 49
Hypoglycaemia: current management and controversies
Choudhary, P., & Amiel, S. A. (2011) · Postgraduate Medical Journal · doi:10.1136/pgmj.2008.068197 · Cited by 56
Fährmann, E. R., ADKINS, L. J., Loader, C. J., Han, H., Rice, K. M., Denvir, J., & Driscoll, H. K. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.10.007 · Cited by 47
Pancreatic islet transplantation in the treatment of diabetes mellitus
Shapiro, A. M. J., Ryan, E. A., & Lakey, J. R. T. (2001) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1053/beem.2001.0138 · Cited by 47
Ferguson, S. C., Strachan, M. W. J., Janes, J., & Frier, B. M. (2001) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.202 · Cited by 45
D’Auria, S., DiCésare, N., Staiano, M., Gryczynski, Z. K., Rossi, M., & Lakowicz, J. R. (2002) · Analytical Biochemistry · doi:10.1006/abio.2001.5544 · Cited by 47
Mitchell, B. D., He, X., Sturdy, I. M., Cagle, A. P., & Settles, J. A. (2016) · Endocrine Practice · doi:10.4158/ep15831.or · Cited by 46
Hayek, A. A., Robert, A. A., Braham, R. B., Issa, B. A., & Sabaan, F. S. A. (2015) · Medical Principles and Practice · doi:10.1159/000375306 · Cited by 53
Regional brain activation during hypoglycemia in type 1 diabetes
Musen, G., Simonson, D. C., Bolo, N. R., Driscoll, A., Weinger, K., Raji, A., Théberge, J., Renshaw, P. F., & Jacobson, A. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2007 · Cited by 33
Optimising the Benefits of SGLT2 Inhibitors for Type 1 Diabetes
Evans, M., Hicks, D., Patel, D., Patel, V., McEwan, P. C., & Dashora, U. K. (2019) · Diabetes Therapy · doi:10.1007/s13300-019-00728-6 · Cited by 48
Glucagon as a Treatment of Severe Hypoglycemia
Pearson, T. L. (2008) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721707312400 · Cited by 49
Haugstvedt, A., Wentzel‐Larsen, T., Aarflot, M., Rokne, B., & Graue, M. (2015) · BMC Endocrine Disorders · doi:10.1186/1472-6823-15-2 · Cited by 46
McCrimmon, R. J., Evans, M. L., Jacob, R. J., Fan, X., Zhu, Y., Shulman, G. I., & Sherwin, R. S. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00195.2002 · Cited by 45
Hypoglycemia: A Complication of Diabetes Therapy in Children
Ryan, C. M., Gurtünca, N., & Becker, D. J. (2005) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2005.08.002 · Cited by 50
Koivikko, M. L., Tulppo, M. P., Kiviniemi, A. M., Kallio, M., Perkiömäki, J. S., Salmela, P. I., Airaksinen, J. K. E., & Huikuri, H. V. (2012) · Diabetes Care · doi:10.2337/dc11-2120 · Cited by 46
Assessing hyperglycemia avoidance in people with Type 1 diabetes
Singh, H., Gonder-Frederick, L. A., Schmidt, K., Ford, D., Vajda, K., Hawley, J. S., & Cox, D. J. (2014) · Diabetes Management · doi:10.2217/dmt.14.3 · Cited by 51
Tkacs, N. C., Pan, Y., Raghupathi, R., Dunn-Meynell, A. A., & Levin, B. E. (2005) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600152 · Cited by 44
Complications of pediatric and adolescent type 1 diabetes mellitus
Brink, S. J. (2001) · Current Diabetes Reports · doi:10.1007/s11892-001-0010-1 · Cited by 45
McCall, A. L., & Kovatchev, B. P. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300102 · Cited by 51
Update on Islet Cell Transplantation for Type 1 Diabetes
Agarwal, A., & Brayman, K. L. (2012) · Seminars in Interventional Radiology · doi:10.1055/s-0032-1312569 · Cited by 48
Current challenges in islet transplantation
Leitão, C. B., Cure, P., Tharavanij, T., Baidal, D. A., & Alejandro, R. (2008) · Current Diabetes Reports · doi:10.1007/s11892-008-0057-3 · Cited by 43
Abualhassan, N., Sapozhnikov, L., Pawlick, R., Kahana, M., Pepper, A., Bruni, A., Gala-Lopez, B., Kin, T., Mitrani, E., & Shapiro, A. M. J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0156053 · Cited by 44
Insulin resistance, role of metformin and other non-insulin therapies in pediatric type 1 diabetes
Bacha, F. F., & Bartz, S. K. (2015) · Pediatric Diabetes · doi:10.1111/pedi.12337 · Cited by 45
Hope, S. V., Taylor, P. J., Shields, B. M., Hattersley, A. T., & Hamilton, W. T. (2017) · Primary care diabetes · doi:10.1016/j.pcd.2017.08.004 · Cited by 51
Selection of Implantation Sites for Transplantation of Encapsulated Pancreatic Islets
Zhu, H., Li, W., Liu, Z., Li, W., Chen, N., Lu, L., Zhang, W., Wang, Z., Wang, B., Pan, K., et al. (2017) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2017.0311 · Cited by 46
Clinical Evaluation of MK ‐2640: An Insulin Analog With Glucose‐Responsive Properties
Krug, A. W., Visser, S. A. G., Tsai, K., Kandala, B., Fancourt, C., Thornton, B., Morrow, L., Kaarsholm, N. C., Bernstein, H. S., Stoch, S. A., et al. (2018) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1215 · Cited by 43
Artificial Pancreas: Current Progress and Future Outlook in the Treatment of Type 1 Diabetes
Ramli, R., Reddy, M., & Oliver, N. S. (2019) · Drugs · doi:10.1007/s40265-019-01149-2 · Cited by 48
Once-Daily Insulin Glargine Compared with Twice-Daily NPH Insulin in Patients with Type 1 Diabetes
Hershon, K. S., Blevins, T., Mayo, C. A., & Rosskamp, R. (2004) · Endocrine Practice · doi:10.4158/ep.10.1.10 · Cited by 43
Potential new strategies to prevent the development of diabetic retinopathy
Mohr, S. (2004) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.13.3.189 · Cited by 42
Empagliflozin, a sodium glucose co-transporter 2 inhibitor, in the treatment of type 1 diabetes
Lamos, E. M., Younk, L. M., & Davis, S. N. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.909407 · Cited by 43
Haque, M. R., Kim, J., Park, H., Lee, H. S., Lee, K. W., Al-Hilal, T. A., Jeong, J., Ahn, C., Lee, D. S., Kim, S. J., et al. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.04.021 · Cited by 43
Hope, S. V., Knight, B., Shields, B. M., Hill, A. V., Choudhary, P., Strain, W. D., McDonald, T. J., & Jones, A. G. (2017) · Diabetologia · doi:10.1007/s00125-017-4449-2 · Cited by 47
Glycemic Variability and Brain Glucose Levels in Type 1 Diabetes
Hwang, J. J., Jiang, L., RANGEL, E. S., Fan, X., Ding, Y., Lam, W., LEVENTHAL, J., Dai, F., Rothman, D. L., Mason, G. F., et al. (2018) · Diabetes · doi:10.2337/db18-0722 · Cited by 40
Hypoglycemia in Type 1 Diabetes Mellitus: Pathophysiology and Prevention
Dagogo-Jack, S. (2004) · Treatments in Endocrinology · doi:10.2165/00024677-200403020-00004 · Cited by 40
TH1/TH2 cytokine balance in patients with both type 1 diabetes mellitus and asthma
Rachmiel, M., Bloch, O., Bistritzer, T., Weintrob, N., Ofan, R., Koren‐Morag, N., & Rapoport, M. J. (2006) · Cytokine · doi:10.1016/j.cyto.2006.04.012 · Cited by 40
Torimoto, K., Okada, Y., Hajime, M., Tanaka, K., & Tanaka, Y. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0017 · Cited by 43
Thomas, R. M., Aldibbiat, A. M., Griffin, W., Cox, M. A. A., Leech, N., & Shaw, J. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02196.x · Cited by 40
Metadata
- Authors
- The Diabetes Control and Complications Trial Research Group
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- The Diabetes Control and Complications Trial Research Group
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 1997-02-01
- Volume
- 46
- Issue
- 2
- Pages
- 271-286
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W4252271922
- Semantic Scholar
- 0b14f6e58470afda31b2a9daa1c3fb61be7dad5a
- Cited by
- 746
- References
- 0
- Citations by year
- 2026: 8 · 2025: 13 · 2024: 14 · 2023: 16 · 2022: 23 · 2021: 21 · 2020: 30 · 2019: 34 · 2018: 41 · 2017: 36 · 2016: 36 · 2015: 47 · 2014: 45 · 2013: 36 · 2012: 33
- FWCI
- 5.13
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- severe hypoglycemia, type 1 diabetes, intensive insulin therapy, baseline characteristics, Diabetes Control and Complications Trial, hypoglycemia risk factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.